We further identified the alternative splicer PTBP2 from proteomic analysis of NBs with distinct prognoses and verified that monocytes and Mφs polarized by PTBP2-treated NB cells also act back to regulate tumor cell proliferation. This evidence concerns the gene PTBP2 and Nijmegen breakage syndrome.